Jesduvroq Tablet, Film Coated
Product Images NDC 0173-0897

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Jesduvroq (NDC 0173-0897). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glaxosmithkline Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

N [(1,3 Dicyclohexylhexahydro-2,4,6-trioxopyrimidin-5-yl) Carbonyl]glycine Chemical Structure (Jesduvroq Spl Graphic 01)

FDA Label Image

Jesduvroq 1 mg Tablet 30 Count Label (Jesduvroq Spl Graphic 02)

This is a description of a medication with NDC number 0173-0897-13. Each tablet contains 1 mg of depodustat. It is a prescription-only drug that should be swallowed whole and not cut, crushed, or chewed. The tablets should be stored at room temperature between 20°C to 25°C with excursions permitted between 15°C and 30°C. The user should not use the drug if the printed safety seal under the cap is broken or missing. The recommended dosage is provided in the prescribing information. The medication is manufactured by GlaxoSmithKline in Singapore, and its trademarks are owned or licensed to the GSK group of companies.*

FDA Label Image

Jesduvroq 2 mg Tablet 30 Count Label (Jesduvroq Spl Graphic 03)

This is a prescription-only medication called Jesduvroq (daprodustat) tablets, with each tablet containing 2mg of daprodustat. Patients should swallow the tablets whole and not cut, chew or crush them. The recommended dosage is indicated in the prescribing information. It is manufactured by GlaxoSmithKline in Durham, NC, and is a product of Singapore. Patients must be given the accompanying medication guide, and the tablets must be stored between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C and 30°C (59°F to 86°F). If the printed safety seal under the cap is broken or missing, the medication should not be used. Trademarks are owned by or licensed to the GSK group of companies.*

FDA Label Image

Jesduvroq 4 mg Tablet 30 Count Label (Jesduvroq Spl Graphic 04)

Jesduvroq is a prescription medication containing 4mg of daprodustat, available in a bottle with 30 tablets. Patients should not cut, chew or crush the tablets and should be given the accompanying medication guide. The recommended dosage should be followed and the medication should be stored between 15°C and 30°C. Jesduvroq is manufactured by GlaxoSmithKline in Singapore.*

FDA Label Image

Jesduvroq 6 mg Tablet 30 Count Label (Jesduvroq Spl Graphic 05)

This text provides information about a prescription drug called Jesduvroq (daprodustat), which comes in tablet form containing 6 mg of daprodustat. It advises patients not to cut, crush, or chew the tablets, and to store them at a temperature range of 20°C to 25°C. The medication guide should be provided to each patient, and the recommended dosage should be checked in the prescribing information. Trademarks are owned by or licensed to the GSK group of companies, and the product is manufactured by GlaxoSmithKline in Durham, NC, and produced in Singapore.*

FDA Label Image

Jesduvroq 8 mg Tablet 30 Count Label (Jesduvroq Spl Graphic 06)

Each tablet of this medication contains 8 mg of daprodustat. Swallow the tablets whole without cutting, crushing, or chewing them. Store the tablets at a temperature between 20°C to 25°C (68°F to 77°F), with permitted excursions within 15°C-30°C (59°F-86°F). Do not use if the printed safety seal under the cap is broken or missing. The dosage should be prescribed by a medical professional, and a licensed medication guide should be dispensed to each patient. This product is manufactured by GlaxoSmithKline in Singapore, and 30 tablets are included in each container.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.